Point-of-care test for the detection of MDMA (ecstasy) in clinical and forensic samples. Provides rapid results for substance abuse screening in healthcare settings.
Manufactured by
Shanghai, China
The two Production Plants of Shanghai Chemtron Biotech Co., Ltd. are located in the International Medical Park, Zhangjiang Development Zone, Pudong New District and Xiasha Town, Pudong New District in Shanghai. Chemtron was founded in January 2001, a high-tech enterprise in Shanghai, a vice president unit of the medical laboratory industry branch of the health industry management association, and a patent demonstration enterprise in Shanghai. Chemtron specializes in R D, production, sales and services of in-vitro rapid detection of diagnostic reagents. Chemtron has Production Plants over 17000 square meters with facilities for advanced R D, production, quality inspection equipment and instruments of in-vitro diagnostic reagent with an annual production capacity of 320 million. In San Diego, California, the United States, Chemtron (U.S.) company has established a sole-owned product development center and production plant. At present, there are 194 employees, 110 with Bachelor s degree or above including 3 Doctors, 10 Masters, accounting for 52.9% of the total employees of the company. In 2004, Chemtron passed the international certification of ISO13485 authoritative quality system; in March 2005, Chemtron passed the GMP certification of the State Food and drug administration; in 2009, it was listed in the biomedical industrialization project of Shanghai government; Chemtron s main products obtained the CE certificate in EU; 12 drug testing products series have obtained the FDA certification of the United States. Chemtron has established a first-class “Chemtron R D technology center” in the United States and China. Based on the platform of monoclonal antibody technology and laboratory medicine technology, Chemtron has speeded up the R D and marketing of its products. Chemtron has continuously developed and launched fast, sensitive, specific and accurate in-vitro diagnostic products. Chemtron now has a series of in-vitro diagnostic reagents under the national registered trademark Chemtrue , with a total of 6 series of products of more than 40 varieties: such as drug detection; tumor detection; infectious disease detection; cardiovascular disease detection; hormone detection and POCT rapid quantitative intelligent instrument with supporting CRP, HCG, MAU, cTnI, myocardial infarction three-in-one, PCT, D2 polymer and other products. Chemtron has always adhered to the business philosophy of quality, reputation, service and sincerity and the quality policy of perfect quality, standardized management, innovation and sincere service . Chemtron s products are sold to over 70 countries and regions around the world, such as the United States, Russia, Europe, South America, Middle East, East Asia, etc. Chemtron is willing to work together with you to relieve human suffering!
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
POCBio (Nexlab Co., Ltd.)
China · 7 relevant products
Hangzhou Pefectech Biotechnology Co., Ltd.
China · 3 relevant products
AssureTech.(Hangzhou) Co.,Ltd.
China · 6 relevant products
NTBIO Diagnostics Inc.
Canada · 7 relevant products
Acmex Bio-Technology (Chongqing) Co.,Ltd
China · 1 relevant product
HANGZHOU BIOEAST BIOTECH CO.,LTD
China · 3 relevant products
Triplex International Biosciences(China) Co.,LTD.
China · 1 relevant product
ASC LLC
United States · 5 relevant products
ELVINCO MED TECH PT
Indonesia · 5 relevant products
HANGZHOU LAIHE BIOTECH CO.,LTD
China · 5 relevant products
43 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 108 closest product alternatives
POCBio (Nexlab Co., Ltd.) · China
A rapid screening test for the detection of MDMA (ecstasy) in biological samples. This test is used for drug of abuse screening in clinical and occupational monitoring.
Hangzhou Pefectech Biotechnology Co., Ltd. · China
A rapid diagnostic test device for detecting MDMA (ecstasy) in urine samples. This test is designed for quick and reliable drug of abuse screening with high precision and sensitivity.
AssureTech.(Hangzhou) Co.,Ltd. · China
In vitro diagnostic test for methylene dioxy methamphetamine detection. Enables quick substance screening in clinical environments.
NTBIO Diagnostics Inc. · Canada
Rapid immunoassay test for detection of MDMA (ecstasy) in urine samples. Provides qualitative results suitable for preliminary screening.
Acmex Bio-Technology (Chongqing) Co.,Ltd · China
One-Step Ecstasy (MDMA) Test Kit is a rapid and convenient immunochromatographic assay for the qualitative detection of 3,4-Methylenedioxymethamphetamine (MDMA) and its metabolites in urine samples at or above the cutoff level of 500 ng/ml. The device is designed for over-the-counter use as well as professional use.
HANGZHOU BIOEAST BIOTECH CO.,LTD · China
Rapid diagnostic test uncut sheet for MDMA (ecstasy) detection in hair samples using colloidal gold technology. Dimensions of 6cm×30cm with sensitivity of 20 ng/mL.
HANGZHOU BIOEAST BIOTECH CO.,LTD · China
Hair-based diagnostic test sheet for detecting MDMA (methylenedioxymethamphetamine) using fluorescence immunochromatography method. Dimensions are 6cm×30cm with a detection sensitivity of 1ng/ml or 2ng/ml.
HANGZHOU BIOEAST BIOTECH CO.,LTD · China
Urine-based diagnostic test sheet for detecting MDMA (methylenedioxymethamphetamine) using colloidal gold immunochromatography method. Dimensions are 6cm×30cm with a detection sensitivity of 1000ng/ml.
Triplex International Biosciences(China) Co.,LTD. · China
A diagnostic test kit for simultaneous detection of methamphetamine, ketamine, and MDMA (dimethylenedioxy amphetamine) using the colloidal gold method. This is a drug screening product designed for toxicology testing applications.
ASC LLC · United States
Ecstasy (MDMA) screening test kit with 500 ng/mL detection threshold for on-site rapid testing. Provides quick results for occupational and clinical drug screening applications.
ELVINCO MED TECH PT · Indonesia
Rapid diagnostic dip card for simultaneous detection of 10 drug metabolites including amphetamine, morphine, THC, methamphetamine, benzodiazepine, cocaine, soma, MDMA, methadone, and PCP in urine samples.
NTBIO Diagnostics Inc. · Canada
Rapid immunoassay test cup detecting 14 drugs of abuse including amphetamine, barbiturates, benzodiazepines, cocaine, methamphetamine, MDMA, morphine, opioids, oxycodone, PCP, THC, ketamine, and methadone. Health Canada and CE certified with ISO 13485:2016 compliance.
96 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products